Back to search results

Selective Antigen Specific T Cells and CAR T Cells in Subjects With Relapsed/Refractory Embryonal Tumors (SABRE)

Abroad (travel likely)RecruitingPHASE1

Conditions

Rhabdomyosarcoma · Ewing Sarcoma · Neuroblastoma · Wilms Tumor

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Children's National Hospital, Washington D.C., District of Columbia, United States

    Contact: Study coordinator (Fahmida Hoq, MBBS, MS) · FHOQ@childrensnational.org · 202-476-3634
    Amy Hont, MD (Sub-investigator)

  • Childrens National Hospital, Washington D.C., District of Columbia, United States

    Contact: Study coordinator (Holly Meany, MD) · HMeany@childrensnational.org · 202-476-5697
    Contact: Principal Investigator (Holly Meany, MD)
    Amy Hont, MD (Sub-investigator)
Study leads

  • Holly Meany, MD

    Principal Investigator

    Children's National Research Institute

  • Amy Hont, MD

    Principal Investigator

    Children's National Research Institute

View source on ClinicalTrials.gov(opens in a new tab)